Upload
ngonguyet
View
220
Download
1
Embed Size (px)
Citation preview
Global Cluster Hub workshop: Cluster Internationalisation
Thailand Center of Excellence for Life Sciences ( T CELS ) DR. NARES DAMRONGCHAI
CEO
November 3, 2015 @ BIO-Europe, Munich, Germany
Thailand as the gateway to ASEAN
• Association of Southeast Asian Nations (ASEAN), and easy access into the Greater Mekong sub-region, where newly emerging markets offer great business potential.
• Offers convenient trade with China, India, largest growing economic market.
• ASEAN Economic Community (AEC), will enter into force by the end of 2015.
New Comer with a Vision
To make Thailand a world-class center for life sciences innovation and investment
Mission: Life Sciences Value Chain Execution
TCELS is a Thai government public organization. Our mission is to connect, construct and foster life sciences industry value chain through translation and acceleration of research to market
Research community Entrepreneurs
investors Public sector
R&D Focus: Bioresources and Tropical Diseases National Center for Biotechnology and Genetic Engineering
◦ Website: http://www.biotec.or.th
◦ Thailand Bioresource Research Center (TBRC)
◦ Medical Molecular Biology Research Unit ◦ Malaria
◦ Tuberculosis
◦ National Biopharmaceutical Facility (NBF)
FOCUS: Cell and Gene Therapy 1. Excellent Center for Drug Discovery (early 2016-) 2. Pilot Plant for Cell and Tissue Production Center (early 2016-)
cGMP Facility
Early Phase
Late Phase
- Grade A, B, C and D clean rooms, BSL2 (Biosafety level 2)
- Quality management system (QA/QC) - Process development for the
manufacture of cells for phase I, II clinical trials
3. Automated cell processing system (early 2016-)
Source: Compiled from JCI certifications and data from Development Bank of Japan, 2014
Number of Medical Institutions in Major Asian Countries with JCI Certifications
Clinical Trials
• Data Management Unit: Tropical Medicine; MU, CU, TU, CMU
• Ethics: Joint Research Ethical Committees (JREC) for multi-center studies, FERCIT,
FERCAP
• CROs: ACLIRES, AGR, Clinical Development Services:
The Covance Advantage, etc.
• Bioequivalence Center: IBS, with ICH-GCP and OECD-GLP guidelines, study
protocols, internal SOPs and relevant regulatory requirements.
• Strong hospital sector growth reflecting the ongoing modernization of the healthcare industry Private: The Bumrungrad International Clinical Research Center (BICRC),
Public Clinical Research Center: Siriraj, CMU, KK, CRI, CU, Trop Med (Follow GCP Guideline)
13
Track Records of Success in Medical Tourisms
2010 2011 2012
No. of Medical tourists (person)
1,980.000 2,240,000 2,530
Estimated Revenue (Mil.USD)
2,400 3,000 4,300
Top 5 medical tourists by nationality
Japan ASEAN Middle East US UK
Japan ASEAN Middle East US UK
Japan US UK Middle East Australia
Medical
Hub Tourism Medical
Tourism
Resour
ces
R&D Technolo
gy
Raw &
Material
Manufactu
ring Investment &
Fund Infrastruc
ture
Regulatio
n
Conceptual Framework
Sustainable
Thailand’s Special Economic Zone: Regional cluster development
Project “Medicopolis” is a plan to develop regional life sciences clusters based on indigenous capability, high technology, and tourism.
There are currently 3 potential locations in Eastern, Northeastern, and Southern Thailand.
Potentially to become “Life Sciences Zone” focusing on specific sectors e.g. medical devices and natural products.
MEDICOPOLI
S
by
TCELS
MEDICOPOLI
S
by
TCELS
MEDICOPOLI
S
by
TCELS
Our Challenges Attracting international partners has been first priority
◦ Political stability?
◦ Regulatory harmonization?
Investment regimes and incentives ◦ Are they competitive enough?
Human resources ◦ Researchers – talent mobility program
◦ Commercialization professionals
18
Coordinating Center
& Program • HRD APEC LSIF - Provide Strategic Direction
Regional
Implementation Center Provide up to date
contents for training
Building APEC economies capacity to commercialize their biomedical research & innovation
Contact Dr. Nares Damrongchai
www.tcels.org
20